BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 25999186)

  • 1. Left atrial catheter ablation subsequent to Watchman® left atrial appendage device implantation: a single centre experience.
    Walker DT; Phillips KP
    Europace; 2015 Sep; 17(9):1402-6. PubMed ID: 25999186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.
    Calvo N; Salterain N; Arguedas H; Macias A; Esteban A; García de Yébenes M; Gavira JJ; Barba J; García-Bolao I
    Europace; 2015 Oct; 17(10):1533-40. PubMed ID: 25935163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The WATCHMAN left atrial appendage closure device for atrial fibrillation.
    Möbius-Winkler S; Sandri M; Mangner N; Lurz P; Dähnert I; Schuler G
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22395336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices.
    Wintgens LIS; Klaver MN; Swaans MJ; Alipour A; Balt JC; van Dijk VF; Rensing BJWM; Wijffels MCEF; Boersma LVA
    Europace; 2019 Mar; 21(3):428-433. PubMed ID: 30380015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.
    Turagam MK; Lavu M; Afzal MR; Vuddanda V; Jazayeri MA; Parikh V; Atkins D; Bommana S; DI Biase L; Horton R; Bai R; Swarup V; Cheng J; Natale A; Lakkireddy D
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):139-146. PubMed ID: 27943538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation.
    Fassini G; Conti S; Moltrasio M; Maltagliati A; Tundo F; Riva S; Dello Russo A; Casella M; Majocchi B; Zucchetti M; Russo E; Marino V; Pepi M; Tondo C
    Europace; 2016 Nov; 18(11):1705-1710. PubMed ID: 27402623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
    Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
    J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: a single-centre prospective study.
    Da Costa A; Ben H'dech M; Romeyer-Bouchard C; Bisch L; Gate-Martinet A; Levallois M; Isaaz K
    Arch Cardiovasc Dis; 2013; 106(8-9):423-32. PubMed ID: 23906679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices.
    Heeger CH; Rillig A; Lin T; Mathew S; Deiss S; Lemes C; Botros M; Metzner A; Wissner E; Kuck KH; Ouyang F; Tilz RR
    Heart Rhythm; 2015 Jul; 12(7):1524-31. PubMed ID: 25769512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up.
    Phillips KP; Pokushalov E; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2018 Jun; 20(6):949-955. PubMed ID: 29106523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
    Reddy VY; Doshi SK; Sievert H; Buchbinder M; Neuzil P; Huber K; Halperin JL; Holmes D;
    Circulation; 2013 Feb; 127(6):720-9. PubMed ID: 23325525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Appendage Closure Under Intracardiac Echocardiographic Guidance: Feasibility and Comparison With Transesophageal Echocardiography.
    Matsuo Y; Neuzil P; Petru J; Chovanec M; Janotka M; Choudry S; Skoda J; Sediva L; Kurabayashi M; Reddy VY
    J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27680664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device.
    Enomoto Y; Gadiyaram VK; Gianni C; Horton RP; Trivedi C; Mohanty S; Di Biase L; Al-Ahmad A; Burkhardt JD; Narula A; Janczyk G; Price MJ; Afzal MR; Atoui M; Earnest M; Swarup V; Doshi SK; van der Zee S; Fisher R; Lakkireddy DR; Gibson DN; Natale A; Reddy VY
    Heart Rhythm; 2017 Jan; 14(1):19-24. PubMed ID: 27771552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoballoon Ablation and Bipolar Voltage Mapping in Patients With Left Atrial Appendage Occlusion Devices.
    Huang HD; Krishnan K; Sharma PS; Kavinsky CJ; Rodriguez J; Ravi V; Larsen TR; Trohman RG
    Am J Cardiol; 2020 Nov; 135():99-104. PubMed ID: 32866447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.
    Waksman R; Pendyala LK
    Am J Cardiol; 2015 Feb; 115(3):378-84. PubMed ID: 25579887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Atrial Appendage Electrical Isolation and Concomitant Device Occlusion to Treat Persistent Atrial Fibrillation: A First-in-Human Safety, Feasibility, and Efficacy Study.
    Panikker S; Jarman JW; Virmani R; Kutys R; Haldar S; Lim E; Butcher C; Khan H; Mantziari L; Nicol E; Foran JP; Markides V; Wong T
    Circ Arrhythm Electrophysiol; 2016 Jul; 9(7):. PubMed ID: 27406602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
    Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
    Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study.
    Swaans MJ; Post MC; Rensing BJ; Boersma LV
    J Am Heart Assoc; 2012 Oct; 1(5):e002212. PubMed ID: 23316289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.